Harlan Laboratories performs a full range
of regulatory toxicology studies to support the pharmaceutical
industry.
The following studies are routinely
performed:
- Single dose
- Maximum tolerated dose
- Local tolerance
- Repeat-dose, 2, 4, 13, 26, 39 or 52 weeks
duration
- Safety pharmacology
- Reproductive toxicology
- Carcinogenicity
- Carcinogenicity studies with genetically modified
animal models (rasH2)
The repeat-dose studies can be designed with recovery groups and
routinely include toxicokinetic assessment.